LSWC Takes the Stage at SynBioBeta 2026
- Apr 19
- 1 min read

The Life Sciences Workforce Collaborative (LSWC) will be represented on the global stage this May at SynBioBeta 2026 Synthetic Biology Summit, one of the premier gatherings at the intersection of biology, technology, and innovation.
Maria Thacker Goethe will moderate a featured session, “Bio-Ready America: Advancing Bioliteracy to Power the U.S. Bioeconomy,” highlighting the critical role of workforce development and bioliteracy in maintaining U.S. leadership in biotechnology.
She will be joined by an esteemed panel of leaders, including:
Drew Endy, Hoover Institution Fellow, Stanford University
Stuart Sevier, President, IMI
Amy Jenkins, Senior Director, Strategy & Operations, AstraZeneca
Taking place May 4–7 in San Jose, the summit will convene more than 2,000 founders, investors, scientists, and industry leaders shaping the future of the bioeconomy. From AI-driven drug discovery and biomanufacturing to sustainable materials and next-generation therapeutics, SynBioBeta explores how programmable biology is transforming industries across health, food, energy, and beyond.
Special Offer for LSWC Network: LSWC collaborators can receive 20% off startup-priced tickets using code LSWC2026 at registration. Learn more at: https://www.syntheticbiologysummit.com/





Comments